Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital ...Middle East

SAN DIEGO and CALGARY, AB, April 10, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, has entered into a share purchase agreement (SPA) with Alumni Capital LP (Alumni), an institutional...

Hence then, the article about oncolytics biotech funds pelareorep s ongoing clinical development with a share purchase agreement in partnership with alumni capital was published today ( Friday 11/04/2025 - 01:18 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital )

Also on site :

• Tottenham Hotspur book and used pyjamas among ‘most disappointing’ Christmas gifts, survey reveals
• National Oil Companies Quietly Set The Pace For The Next Decade
• Children received inflation-busting pocket money pay rises in 2025, figures show